Plunkett Research Online: Celgene Corporation

CELGENE CORPORATION (CELG:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Celgene Corporation is a global biopharmaceutical company involved in discovering, developing and commercializing cancer and immune-inflammatory related disease treatment therapies. Celgene’s current preclinical and clinical-stage pipeline of new drug candidates and cell therapies include both smal.....



Celgene Corporation
Ticker: CELG
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 908 673-9000
Fax: 908 673-9001
Address: 86 Morris Avenue
Summit, NJ 07901 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Cancer & Immune-Inflammatory Related Diseases Drugs
ContactsDescription
Mark AllesCEO/Chairman of the Board/Director
Peter KelloggCFO/Chief Accounting Officer/Executive VP
See More
Celgene Corporation is a global biopharmaceutical company involved in discovering, developing and commercializing cancer and immune-inflammatory related disease treatment therapies. Celgene’s current preclinical and clinical-stage pipeline of new drug candidates and cell therapies include both smal.....See More See More

Auditor: KPMG LLP
Legal Advisor: Proskauer Rose LLP
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Revlimid
Abraxane
Pomalyst/Imnovid
Vidaza
Thalomid
IDHIFA
Otezla
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: